retatrutide glp-1 gip glucagon receptor agonist What Is (RETA)? The Triple Explained Retatrutide 40mg | Triple GIP/GLP-1/Glucagon

Defining IR in patients with T1D in the clinical setting is also challenging

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 17.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 169.00 per year only 14.08 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout References Parker, J

Additionally, tirzepatide was found to have a more pronounced effect compared with the GLP-1 agonist semaglutide in people with T2DM

[DOI] [PMC free article] [PubMed] [Google Scholar] 53.Nonogaki K., Kaji T

[DOI] [PMC free article] [PubMed] [Google Scholar] 49.Buse JB, Garber A, Rosenstock J, et al